Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novartis’ Gleevec Approved for Recurrence of Tumors
Novartis’ Gleevec Approved for Recurrence of Tumors
Novartis’ Gleevec Approved for Recurrence of Tumors
Submitted by
admin
on December 22, 2008 - 7:45am
Source:
Bloomberg
News Tags:
Novartis
Gleevac
cancer
Headline:
Novartis’ Gleevec Approved for Recurrence of Tumors
Do Not Allow Advertisers to Use My Personal information
